Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells

Biochemical and Biophysical Research Communications

Volumn 367, Issue 2, 2008, Pages 491-496

  Kabuyama, Yukihito ^a   Kitamura, Takuya ^a   Yamaki, Junko ^a   Homma, Miwako K ^a   Kikuchi, Shin ichi ^a   Homma, Yoshimi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hydrogen peroxide; Rheumatoid arthritis

Indexed keywords

HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SYNOVIAL MEMBRANE; THIOREDOXIN REDUCTASE 1;

EID: 38349081159     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.178     Document Type: Article

References (29)

1. Gay S., Gay R.E., and Koopman W.J. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann. Rheum. Dis. 52 Suppl. 1 (1993) S39-S47
2. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996) 397-440
3. Satoh K., Kikuchi S., Sekimata M., Kabuyama Y., Homma M.K., and Homma Y. Involvement of ErbB-2 in rheumatoid synovial cell growth. Arthritis Rheum. 44 (2001) 260-265
4. Kitamura T., Sekimata M., Kikuchi S., and Homma Y. Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells. Am. J. Physiol. Cell Physiol. 289 (2005) C82-C88
5. Lemaire R., Huet G., Zerimech F., Grard G., Fontaine C., Duquesnoy B., and Flipo R.M. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br. J. Rheumatol. 36 (1997) 735-743
6. Huet G., Flipo R.M., Colin C., Janin A., Hemon B., Collyn-d'Hooghe M., Lafyatis R., Duquesnoy B., and Degand P. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum. 36 (1993) 772-780
7. Grootveld M., Henderson E.B., Farrell A., Blake D.R., Parkes H.G., and Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem. J. 273 (1991) 459-467
8. Kalavacherla U.S., Ishaq M., Rao U.R., Sachindranath A., and Hepsiba T. Malondialdehyde as a sensitive marker of inflammation in patients with rheumatoid arthritis. J. Assoc. Phys. India 42 (1994) 775-776
9. Dai L., Lamb D.J., Leake D.S., Kus M.L., Jones H.W., Morris C.J., and Winyard P.G. Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid arthritis patients. Free Radic. Res. 32 (2000) 479-486
10. Bashir S., Harris G., Denman M.A., Blake D.R., and Winyard P.G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52 (1993) 659-666
11. Cerhan J.R., Saag K.G., Merlino L.A., Mikuls T.R., and Criswell L.A. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am. J. Epidemiol. 157 (2003) 345-354
12. Hagfors L., Leanderson P., Skoldstam L., Andersson J., and Johansson G. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr. J. 2 (2003) 5
13. Heliovaara M., Knekt P., Aho K., Aaran R.K., Alfthan G., and Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann. Rheum. Dis. 53 (1994) 51-53
14. Bae S.C., Kim S.J., and Sung M.K. Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J. Am. Coll. Nutr. 22 (2003) 311-315
15. Paredes S., Girona J., Hurt-Camejo E., Vallvé J.C., Olivé S., Heras M., Benito P., and Masana L. Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers. J. Rheumatol. 29 (2002) 2271-2277
16. Kabuyama Y., Hamaya M., and Homma Y. Wavelength specific activation of PI 3-kinase by UVB irradiation. FEBS Lett. 441 (1998) 297-301
17. Tomita T., Kunugiza Y., Tomita N., Takano H., Morishita R., Kaneda Y., and Yoshikawa H. E2F decoy oligodeoxynucleotide ameliorates cartilage invasion by infiltrating synovium derived from rheumatoid arthritis. Int. J. Mol. Med. 18 (2006) 257-265
18. Afuwape A.O., Kiriakidis S., and Paleolog E.M. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol. Histopathol. 17 (2002) 961-972
19. Bucht A., Larsson P., Weisbrot L., Thorne C., Pisa P., Smedegard G., Keystone E.C., and Gronberg A. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin. Exp. Immunol. 103 (1996) 357-367
20. Malemud C.J. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin. Chim. Acta 375 (2007) 10-19
21. McInnes I.B., and Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7 (2007) 429-442
22. Mulherin D.M., Thurnham D.I., and Situnayake R.D. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann. Rheum. Dis. 55 (1996) 837-840
23. Backman J.T., Siegle I., and Fritz P. Immunohistochemical localization of metallothionein in synovial tissue of patients with chronic inflammatory and degenerative joint disease. Virchows Arch. 433 (1998) 153-160
24. Maurice M.M., Nakamura H., Gringhuis S., Okamoto T., Yoshida S., Kullmann F., Lechner S., van der Voort E.A., Leow A., Versendaal J., Muller-Ladner U., Yodoi J., Tak P.P., Breedveld F.C., and Verweij C.L. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 42 (1999) 2430-2439
25. Hitchon C.A., and El-Gabalawy H.S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6 (2004) 265-278
26. Tak P.P., Zvaifler N.J., Green D.R., and Firestein G.S. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today 21 (2000) 78-82
27. Firestein G.S., Nguyen K., Aupperle K.R., Yeo M., Boyle D.L., and Zvaifler N.J. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am. J. Pathol. 149 (1996) 2143-2151
28. Firestein G.S., Echeverri F., Yeo M., Zvaifler N.J., and Green D.R. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA 94 (1997) 10895-10900
29. Becker K., Gromer S., Schirmer R.H., and Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur. J. Biochem. 267 (2000) 6118-6125